Exagen director granted 37,500 stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4/A
Rhea-AI Filing Summary
EXAGEN INC. (XGN) director Bruce C. Robertson reported a grant of 37,500 stock options on June 9, 2026. The options have an exercise price of $4.31 per share, are exercisable for 37,500 shares of common stock, and expire on June 8, 2036. The award becomes fully vested and exercisable on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, subject to his continued board service. An earlier Form 4 had overstated his post-grant holdings; this amendment clarifies that he beneficially owns 37,500 stock options in total.
Insider Trade Summary
Grant/Award: 37,500 shares
Grant/Award
1 txn
Insider
Robertson Bruce C
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option(right to buy) F1, F2 | 37,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option(right to buy) — 37,500 contracts (Direct)
Footnotes (2)
- F1. The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
- F2. On August 19, 2026, the reporting person filed a Form 4 which inadvertently reported that, following his grant of 37,500 stock options, he beneficially owned 55,000 stock options. In fact, as reported in this amendment, the reporting person was granted 37,500 and beneficially owns 37,500 stock options.
Key Figures
Stock options granted: 37,500 options
Exercise price: $4.31 per share
Underlying shares: 37,500 shares
+2 more
5 metrics
Stock options granted
37,500 options
Grant of stock options to Bruce C. Robertson on June 9, 2026
Exercise price
$4.31 per share
Conversion or exercise price of the granted stock options
Underlying shares
37,500 shares
Shares of common stock underlying the stock options
Expiration date
June 8, 2036
Expiration of the stock options granted June 9, 2026
Beneficially owned options after grant
37,500 options
Total options beneficially owned by Bruce C. Robertson as corrected in the amendment
Key Terms
Stock Option, exercise price, beneficially owns, fully vested and exercisable
4 terms
Stock Option financial
"The reporting person was granted 37,500 Stock Option(right to buy)"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price": "4.3100""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
beneficially owns financial
"the reporting person was granted 37,500 and beneficially owns 37,500 stock options"
Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.
fully vested and exercisable financial
"The entire number of shares subject to this option becomes fully vested and exercisable"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did EXAGEN INC. (XGN) report in this Form 4/A?
EXAGEN INC. reported that director Bruce C. Robertson received a grant of 37,500 stock options on June 9, 2026, exercisable for 37,500 shares of common stock at an exercise price of $4.31 per share, expiring June 8, 2036.
What is the exercise price and term of Bruce Robertson’s XGN stock options?
Bruce Robertson’s stock options have an exercise price of $4.31 per share and are exercisable for 37,500 shares of EXAGEN INC. common stock. They expire on June 8, 2036, giving a long-dated option term from the June 9, 2026 grant date.
When do Bruce Robertson’s EXAGEN INC. (XGN) options vest?
The 37,500 options become fully vested and exercisable on the first to occur of (a) the first anniversary of the June 9, 2026 grant date or (b) the next annual meeting of EXAGEN INC. stockholders, subject to his continued service on the board through that vesting date.
How many EXAGEN INC. (XGN) options does Bruce Robertson beneficially own after this filing?
After this grant and as clarified in the amendment, Bruce Robertson beneficially owns 37,500 stock options of EXAGEN INC. An earlier Form 4 had inadvertently reported beneficial ownership of 55,000 options, which this Form 4/A corrects.
Why did EXAGEN INC. (XGN) file this Form 4/A amendment?
The amendment corrects a prior Form 4 filed on August 19, 2026, which inadvertently stated that Bruce Robertson beneficially owned 55,000 stock options after the grant. The accurate figure, as reported here, is a grant of 37,500 options and beneficial ownership of 37,500 options.
AI-generated analysis. How Rhea-AI works. Not financial advice.
